FGF21 was found to upregulate glucose transporter-1 (GLUT1) expression during acute myocardial ischemia, thereby improving energy supply to cardiac myocytes, increasing cell migration and decreasing apoptosis (Hu, Cao & Liu, 2017). This evidence concerns the gene SLC2A1 and myocardial ischemia.